Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
Recruiting
N/A
Interventional Study
Biliary Tract Carcinoma
Radiotherapy
Radio-frequency Ablation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 53 (estimated)
- Sponsor
- National Cancer Center, Korea · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
\[Study objectives\] To evaluate the efficacy and safety of the combined treatment of radiotherapy and endoscopic intraductal radiofrequency ablation in patients with locoregional extrahepatic cholangiocarcinoma.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients 20 years of age or older, who voluntarily agree to participate in the study and sign the informed consent.
2. Patients with cytopathologically diagnosed inoperable extrahepatic cholangiocarcinoma
Exclusion Criteria:
1. Patients who refuse to sign the informed conse…
Contacts